Clearance Summary
IVOBASE HYBRID, IVOBASE HIGH IMPACT received FDA 510(k) clearance under submission number K103391, sponsored by Ivoclar Vivadent, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Dental review panel. The statutory decision date of record is 2011-02-17.
- Submission: K103391
- Applicant / Sponsor: Ivoclar Vivadent, Inc.
- Clearance pathway: Traditional
- Review panel: Dental
- Device class: Class II
- Regulation citation: 21 CFR 872.3760
- Decision date: 2011-02-17
Classification & Regulation
This clearance is catalogued under FDA product code EBI and 21 CFR 872.3760, within the Dental review panel as a Class II device.